13F

HIMS HIMS & HERS HEALTH INC

2026Q1 · CUSIP 433000106 · GLP-1 / Weight Loss · Sector: Healthcare & Biotech

Neutral · No signal
Holders
431
Δ holders QoQ
-52
Breadth percentile
Top 98%
Whale holders
170
Δ whales
-13
Inst. holding value
$3.0B
New positions
86
Closed positions
138
Price momentum (1Q)
+37.0%
Put / Call
30/23

Breadth history (34 quarters)

2020Q4: Δ+0 · h=1 2021Q1: Δ+81 · h=82 2021Q2: Δ+5 · h=87 2021Q3: Δ+24 · h=111 2021Q4: Δ+29 · h=140 2022Q1: Δ-7 · h=133 2022Q2: Δ+6 · h=139 2022Q3: Δ+15 · h=154 2022Q4: Δ+4 · h=158 2023Q1: Δ+33 · h=191 2023Q2: Δ+0 · h=191 2023Q3: Δ+2 · h=193 2023Q4: Δ+6 · h=199 2024Q1: Δ+46 · h=245 2024Q2: Δ+53 · h=298 2024Q3: Δ+10 · h=308 2024Q4: Δ+87 · h=395 2025Q1: Δ+35 · h=430 2025Q2: Δ+81 · h=511 2025Q3: Δ+3 · h=514 2025Q4: Δ-31 · h=483 2026Q1: Δ-52 · h=431 2020Q4: holders=1 2021Q1: holders=82 2021Q2: holders=87 2021Q3: holders=111 2021Q4: holders=140 2022Q1: holders=133 2022Q2: holders=139 2022Q3: holders=154 2022Q4: holders=158 2023Q1: holders=191 2023Q2: holders=191 2023Q3: holders=193 2023Q4: holders=199 2024Q1: holders=245 2024Q2: holders=298 2024Q3: holders=308 2024Q4: holders=395 2025Q1: holders=430 2025Q2: holders=511 2025Q3: holders=514 2025Q4: holders=483 2026Q1: holders=431 -87 -43.5 +0 +43.5 +87 0270540 20Q421Q221Q422Q222Q423Q223Q424Q224Q425Q225Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 10 lit events

Period Percentile Next-1Q return Next-2Q return
2025Q2 Top 2% -18.0% -64.9%
2025Q1 Top 5% -32.3% -42.9%
2024Q4 Top 4% +6.6% -27.9%
2024Q2 Top 3% +33.8% +341.2%
2024Q1 Top 4% +13.7% +32.6%
2023Q1 Top 4% -34.7% -27.3%
2022Q3 Top 9% +66.6% +69.0%
2021Q4 Top 17% -28.8% +33.2%
2021Q3 Top 6% -41.5% -58.4%
2021Q1 Top 2% -18.9% -19.7%

Options Sentiment

Put holders
30
QoQ: -7
Call holders
23
QoQ: -5

See methodology →

Fundamentals

PE (TTM)
EPS (TTM)
$-0.09
EPS YoY
-113.2%
Revenue (TTM)
$2.4B
Revenue YoY
+32.8%
Quarterly Revenue & EPS (4Y)
2022-06-30: $114M 2022-09-30: $145M 2022-12-31: $167M 2023-03-31: $191M 2023-06-30: $208M 2023-09-30: $227M 2023-12-31: $247M 2024-03-31: $278M 2024-06-30: $316M 2024-09-30: $402M 2024-12-31: $481M 2025-03-31: $586M 2025-06-30: $545M 2025-09-30: $599M 2025-12-31: $618M 2026-03-31: $608M 2022-06-30: EPS -0.10 2022-09-30: EPS -0.09 2022-12-31: EPS -0.05 2023-03-31: EPS -0.05 2023-06-30: EPS -0.03 2023-09-30: EPS -0.04 2023-12-31: EPS 0.01 2024-03-31: EPS 0.05 2024-06-30: EPS 0.06 2024-09-30: EPS 0.32 2024-12-31: EPS 0.10 2025-03-31: EPS 0.20 2025-06-30: EPS 0.17 2025-09-30: EPS 0.06 2025-12-31: EPS 0.08 2026-03-31: EPS -0.40 0M 309M 618M $M -0.44 -0.04 0.35 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 70 2024-06-30: PE 194.72024-09-30: PE 43.92024-12-31: PE 114.12025-03-31: PE 95.12025-06-30: PE 58.32025-09-30: PE 69.82025-12-31: PE 32 29 117 204 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)